DUBLIN--(BUSINESS WIRE)--The "Capsule Endoscopy Market to 2027 - Global Analysis and Forecasts by Product; Formulation; End Users, and Geography" report has been added to ResearchAndMarkets.com's ...

LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of ...

The tablet formulation of Brukinsa is supplied as a 160mg dose, allowing patients the convenience of taking only 2 tablets daily. The Food and Drug Administration (FDA) has approved a new tablet ...